Lv38
280 积分 2024-05-22 加入
Nirsevimab: A Review
15天前
已完结
ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines
1个月前
已完结
ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines
1个月前
已关闭
ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines
1个月前
已关闭
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
1个月前
已关闭
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus
2个月前
已完结
Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection
2个月前
已完结
Development of a monoclonal antibody specifically recognizing a linear epitope on the capsid protein of the emerging Group III Getah virus
6个月前
已完结
皖公网安备34019202002308
